Skip to main content
OpenTrials

Clinical trial condition

Hidradenitis Suppurativa

Explore clinical trials studying Hidradenitis Suppurativa. Study availability and eligibility vary by location and protocol.

160 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Hidradenitis Suppurativa trial results

Recruiting

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT07225569

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Scottsdale Clinical Trials- Site Number : 8400006 Scottsdale, Arizona, United States
  • Carbon Health - North Hollywood - NoHo West- Site Number : 8400017 North Hollywood, California, United States
  • Encore Medical Research of Boynton Beach- Site Number : 8400005 Boynton Beach, Florida, United States
  • FXM Clinical Research - Fort Lauderdale- Site Number : 8400013 Fort Lauderdale, Florida, United States
View all 83 locations
View Trial Details
Recruiting

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

NCT06888193

Conditions
Ankylosis, Arthritis, Arthritis, Psoriatic, +23 more
Locations
  • Up0122 105 Santa Monica, California, United States
  • Up0122 103 South Miami, Florida, United States
  • Up0122 104 Boston, Massachusetts, United States
  • Up0122 106 Chapel Hill, North Carolina, United States
View all 14 locations
View Trial Details
Recruiting

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

NCT07049575

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Saguaro Dermatology Phoenix, Arizona, United States
  • First Oc Dermatology Fountain Valley, California, United States
  • Amicis Research Center Valencia Northridge, California, United States
  • Children'S Hospital of Orange County Orange, California, United States
View all 21 locations
View Trial Details
Recruiting

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

NCT07665437

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
  • Novartis Investigative Site CABA, Argentina
  • Novartis Investigative Site Sydney, New South Wales, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
View all 20 locations
View Trial Details

Related conditions